Global Human Papilloma Virus Testing Market: Overview
Science states that all sexually active men and women will at some point in their life contract human papilloma virus. While there is no cure for the disease, most studies state that vaccination at the age of 11 or 12 will prevent the disease. However, with lack of awareness among people, the number of cases of HPV continue to rise in regions of the world. As a result, the need for diagnosis becomes imperative, thus driving growth in the global human papilloma virus testing market.
Over the years, the global market for human papilloma virus testing has grown at a steady pace, and a recent report by Transparency Market Research states that it will grow further in the coming years. The report also sheds light on the prevailing trends in the global human papilloma virus testing market, and also provides extensive details about the size, share, growth, and competitive dynamics.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=65588
Global Human Papilloma Virus Testing Market: Notable Developments
Some of the notable developments of the global human papilloma virus testing market are:
- QIAGEN in September 2015 launched a test that aids diagnosis in women. Called the careHPV test and HC2 collection device, this is QIAGENs effort to detect cases of cancer at an early stage among women.
- Few months before QIAGEN launched its test for HPV in women, Roche, in April 2014, came out with its test for diagnosing cervical cancer. The test was named cobas HPV hat received approval from the US FDA around this time.
- In February 2014, BD Onclarity HPV Assay obtained CE/IVD marking. This opened doors of growth for the company.
Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=65588
Most players in the global human papilloma virus testing market are focusing on improving their existing products and making the process easier for use. At the same time, the cost of testing is also another aspect that most manufacturers are working on. As a result, companies have invested significantly on research and development in the last few years. Some of the prominent players in the global market for HPV testing are Abbott, bioMerieux, Biomedical Diagnostics, CanAG Diagnostics, Epigenomics, CeMines, Bio-Rad, Ipsogen, J&J Diagnostics, Fujirebio, Guided Therapeutics, Gen-Probe, Polartechnics, Qiagen, Radient Pharmaceuticals, Sequenom, Targeted Diagnostics & Therapeutics, OncoLab, Hologic, Roche, and Siemens Healthcare.
Global Human Papilloma Virus Testing Market: Key Trends
Rising Cases of Cervical Cancer to Stoke Demand
World Health Organization (WHO) stated that cervical cancer is the fourth largest reason for death among women in the world today. In 2018 alone, 570,000 new cases were reported accounting to 6.6% of total cancer cases among women. This hints at a trend where the need of products in the global human papilloma virus testing market will grow in the coming years.
Pre Book Human Papilloma Virus Testing Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=65588<ype=S
Awareness to Stimulate Consumption
While it is doctors who confirm diagnosis and prescribe treatment, patients themselves are well aware about the diseases and drugs. Ease access to information on the web, thanks to world-wide penetration of the internet and widespread use of smartphones. As a result, people realize the need to stay healthy and visit a doctor the moment they sense symptoms of a disease. All these aspects are expected to stimulate consumption in the global market for human papilloma virus testing.
Global Human Papilloma Virus Testing Market: Geographical Analysis
The United States is, perhaps, the most developed country when it comes to healthcare. To add to this, people are also aware about the consequences of diseases like cervical cancer. Hence, most women, above the age of 30, undergo an annual check-up. This way, they attempt to ensure that any disease, if detected, can be tended at early stages, preventing the need for painful treatment and loss of money. The rising women population in some countries of Asia Pacific will stem growth in the region. As a result, the demand for products in the global human papilloma virus testing market will improve in the future.
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/